Can LSD Make You Smarter? New Study Shows Positive Results This article by Emma Stone was originally published on Microdose and appears here with permission. Benzinga · Nov 1, 2022
What Do Biden's Cannabis Pardons Mean For Psychedelics? Can This Huge Cultural Shift In America Lead To Legalization? This article by Partick McConnell was originally published on Microdose and appears here with permission. Benzinga · Oct 21, 2022
Ketamine Telehealth: Is It Safe? Is It Here To Stay? This article was originally published on Microdose and appears here with permission. Benzinga · Oct 8, 2022
New Study Looks At Psychedelics And Near-Death Experiences: How They Influence Pespectives On Life And Death This article by Emma Stone was originally published on Microdose and appears here with permission. Benzinga · Oct 7, 2022
Do Psychedelics Change Beliefs? This article by Patrick McConnell was originally published on Microdose and appears here with permission. Benzinga · Sep 19, 2022
Battling With Booze? Here's A Deeper Look At Ketamine for Alcohol Use Disorder This article by Elisabetta Fato was originally published on Microdose and appears here with permission. In the last decades, there has been a growing interest in psychedelics for the treatment of mood and behavioral disorders, among which are substance use disorders. Benzinga · Sep 10, 2022
In Psychedelic Investing, Long-Term Thinking Is Key This article was originally published on Microdose and appears here with permission. In response to a worldwide mental illness epidemic and flood of capital from investing firms, the psychedelic industry has seen explosive growth in recent years. Benzinga · Aug 13, 2022
Right To Try Laws: Psilocybin For End-Of-Life Care Poses Ongoing Battle With The DEA A group of terminally ill patients seeking psilocybin therapy will likely take the Drug Enforcement Administration (DEA) to federal court once again over the agency’s denial to grant access to the treatment under Right To Try (RTT) laws, The Microdose Benzinga · Jul 11, 2022
Psychedelics And Mindfulness: The Future Of Mental Health? This article by Keith Fiveson was originally published on Microdose and appears here with permission. Benzinga · Jun 18, 2022
A Deeper Look At DMT Trials & Studies This article by Elisabetta Fato was originally published on Microdose and appears here with permission. Benzinga · Jun 14, 2022
The Trials And Tribulations Of Psychedelic Research This article by Natasha Sumner was originally published on Microdose and appears here with permission. Benzinga · May 20, 2022
Is The UK Becoming A Global Center For Psychedelic Medicine? This article by Freddie Earlam was originally published on Microdose and appears here with permission. If the industry-defining research already conducted at UK centers such as Imperial College, King’s college or even Exeter University’s recent Ketamine Research isn’t enough to convince you, then two more crucial factors surely will. Firstly, a new ‘accelerated pathway’ has… Benzinga · Apr 8, 2022
A Look At Ketamine And Mental Health This article by Veronica Castillo was originally published on Microdose and appears here with permission. Benzinga · Feb 28, 2022
Entheogens And Plant Medicine: An Introduction This article by Caine Barlow was originally published on Microdose and appears here with permission. Benzinga · Feb 11, 2022
Benzinga · Feb 5, 2022 War On Drugs Update: DEA To Expand List Of Banned Psychedelics This article was originally published on Microdose and appears here with permission.
Benzinga · Jan 25, 2022 Psychedelic Medicine Co. PharmaTher Provides Update On Pipeline And Milestones For 2022 This article was originally published on Microdose and appears here with permission.
Benzinga · Jan 19, 2022 MindMed Successfully Completes Phase 1 Trial Of 18-MC This article was originally published on Microdose and appears here with permission.